US Stock MarketDetailed Quotes

CRDF Cardiff Oncology

Watchlist
  • 2.580
  • +0.110+4.45%
Close Oct 2 16:00 ET
  • 2.580
  • 0.0000.00%
Post 16:30 ET
120.10MMarket Cap-2804P/E (TTM)

Cardiff Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
50.93%163K
146.99%205K
26.42%488K
21.88%156K
51.61%141K
18.68%108K
12.16%83K
7.52%386K
-3.76%128K
8.14%93K
Operating revenue
50.93%163K
146.99%205K
26.42%488K
21.88%156K
51.61%141K
18.68%108K
12.16%83K
7.52%386K
-3.76%128K
8.14%93K
Cost of revenue
Gross profit
Operating expense
3.18%12.71M
-8.22%11.14M
13.93%45.9M
10.17%10.49M
20.64%10.96M
16.92%12.32M
8.85%12.14M
37.91%40.29M
-1.44%9.52M
28.26%9.09M
Selling and administrative expenses
-25.16%3.22M
1.52%3.13M
-1.05%13.04M
-11.47%2.73M
-4.48%2.94M
39.21%4.3M
-21.75%3.08M
11.34%13.18M
-19.74%3.08M
5.02%3.08M
-Selling and marketing expense
-21.40%459K
----
----
----
-20.94%536K
-15.61%584K
----
----
----
17.10%678K
-General and administrative expense
-25.75%2.76M
1.52%3.13M
-1.05%13.04M
-13.05%4.44M
0.17%2.4M
55.05%3.71M
-21.75%3.08M
11.34%13.18M
-4.22%5.1M
2.04%2.4M
Research and development costs
18.37%9.49M
-11.53%8.01M
21.21%32.86M
20.51%7.76M
33.50%8.02M
7.68%8.02M
25.58%9.05M
56.00%27.11M
10.61%6.44M
44.66%6.01M
Operating profit
-2.76%-12.55M
9.28%-10.93M
-13.81%-45.41M
-10.01%-10.33M
-20.32%-10.82M
-16.90%-12.21M
-8.83%-12.05M
-38.28%-39.9M
1.41%-9.39M
-28.51%-8.99M
Net non-operating interest income expense
-23.55%805K
-1.49%926K
157.37%4.07M
36.22%1.01M
133.19%1.07M
316.21%1.05M
623.08%940K
498.86%1.58M
836.71%740K
554.29%458K
Non-operating interest income
-23.55%805K
-1.49%926K
157.37%4.07M
36.22%1.01M
133.19%1.07M
316.21%1.05M
623.08%940K
498.86%1.58M
836.71%740K
554.29%458K
Other net income (expense)
-860.00%-38K
96.40%-4K
74.41%-98K
71.11%-13K
158.33%21K
101.98%5K
-126.53%-111K
-227.67%-383K
-1,000.00%-45K
-340.00%-36K
Other non- operating income (expenses)
-860.00%-38K
96.40%-4K
74.41%-98K
71.11%-13K
158.33%21K
101.98%5K
-126.53%-111K
-2,653.33%-383K
---45K
-1,300.00%-36K
Income before tax
-5.63%-11.78M
10.80%-10.01M
-7.07%-41.44M
-7.36%-9.34M
-13.53%-9.73M
-6.77%-11.15M
-2.09%-11.22M
-36.81%-38.7M
7.89%-8.7M
-23.98%-8.57M
Income tax
Net income
-5.63%-11.78M
10.80%-10.01M
-7.07%-41.44M
-7.36%-9.34M
-13.53%-9.73M
-6.77%-11.15M
-2.09%-11.22M
-36.81%-38.7M
7.89%-8.7M
-23.98%-8.57M
Net income continuous Operations
-5.63%-11.78M
10.80%-10.01M
-7.07%-41.44M
-7.36%-9.34M
-13.53%-9.73M
-6.77%-11.15M
-2.09%-11.22M
-36.81%-38.7M
7.89%-8.7M
-23.98%-8.57M
Minority interest income
Net income attributable to the parent company
-5.63%-11.78M
10.80%-10.01M
-7.07%-41.44M
-7.36%-9.34M
-13.53%-9.73M
-6.77%-11.15M
-2.09%-11.22M
-36.81%-38.7M
7.89%-8.7M
-23.98%-8.57M
Preferred stock dividends
0.00%6K
0.00%6K
0.00%24K
0.00%6K
0.00%6K
0.00%6K
0.00%6K
0.00%24K
0.00%6K
0.00%6K
Other preferred stock dividends
Net income attributable to common stockholders
-5.63%-11.78M
10.79%-10.02M
-7.07%-41.47M
-7.35%-9.34M
-13.52%-9.74M
-6.77%-11.16M
-2.09%-11.23M
-36.78%-38.73M
7.89%-8.7M
-23.96%-8.58M
Basic earnings per share
-4.00%-0.26
12.00%-0.22
-4.49%-0.93
-5.00%-0.21
-10.00%-0.22
-4.17%-0.25
0.00%-0.25
-21.92%-0.89
13.04%-0.2
-17.65%-0.2
Diluted earnings per share
-4.00%-0.26
12.00%-0.22
-4.49%-0.93
-5.00%-0.21
-10.00%-0.22
-4.17%-0.25
0.00%-0.25
-21.92%-0.89
13.04%-0.2
-17.65%-0.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 50.93%163K146.99%205K26.42%488K21.88%156K51.61%141K18.68%108K12.16%83K7.52%386K-3.76%128K8.14%93K
Operating revenue 50.93%163K146.99%205K26.42%488K21.88%156K51.61%141K18.68%108K12.16%83K7.52%386K-3.76%128K8.14%93K
Cost of revenue
Gross profit
Operating expense 3.18%12.71M-8.22%11.14M13.93%45.9M10.17%10.49M20.64%10.96M16.92%12.32M8.85%12.14M37.91%40.29M-1.44%9.52M28.26%9.09M
Selling and administrative expenses -25.16%3.22M1.52%3.13M-1.05%13.04M-11.47%2.73M-4.48%2.94M39.21%4.3M-21.75%3.08M11.34%13.18M-19.74%3.08M5.02%3.08M
-Selling and marketing expense -21.40%459K-------------20.94%536K-15.61%584K------------17.10%678K
-General and administrative expense -25.75%2.76M1.52%3.13M-1.05%13.04M-13.05%4.44M0.17%2.4M55.05%3.71M-21.75%3.08M11.34%13.18M-4.22%5.1M2.04%2.4M
Research and development costs 18.37%9.49M-11.53%8.01M21.21%32.86M20.51%7.76M33.50%8.02M7.68%8.02M25.58%9.05M56.00%27.11M10.61%6.44M44.66%6.01M
Operating profit -2.76%-12.55M9.28%-10.93M-13.81%-45.41M-10.01%-10.33M-20.32%-10.82M-16.90%-12.21M-8.83%-12.05M-38.28%-39.9M1.41%-9.39M-28.51%-8.99M
Net non-operating interest income expense -23.55%805K-1.49%926K157.37%4.07M36.22%1.01M133.19%1.07M316.21%1.05M623.08%940K498.86%1.58M836.71%740K554.29%458K
Non-operating interest income -23.55%805K-1.49%926K157.37%4.07M36.22%1.01M133.19%1.07M316.21%1.05M623.08%940K498.86%1.58M836.71%740K554.29%458K
Other net income (expense) -860.00%-38K96.40%-4K74.41%-98K71.11%-13K158.33%21K101.98%5K-126.53%-111K-227.67%-383K-1,000.00%-45K-340.00%-36K
Other non- operating income (expenses) -860.00%-38K96.40%-4K74.41%-98K71.11%-13K158.33%21K101.98%5K-126.53%-111K-2,653.33%-383K---45K-1,300.00%-36K
Income before tax -5.63%-11.78M10.80%-10.01M-7.07%-41.44M-7.36%-9.34M-13.53%-9.73M-6.77%-11.15M-2.09%-11.22M-36.81%-38.7M7.89%-8.7M-23.98%-8.57M
Income tax
Net income -5.63%-11.78M10.80%-10.01M-7.07%-41.44M-7.36%-9.34M-13.53%-9.73M-6.77%-11.15M-2.09%-11.22M-36.81%-38.7M7.89%-8.7M-23.98%-8.57M
Net income continuous Operations -5.63%-11.78M10.80%-10.01M-7.07%-41.44M-7.36%-9.34M-13.53%-9.73M-6.77%-11.15M-2.09%-11.22M-36.81%-38.7M7.89%-8.7M-23.98%-8.57M
Minority interest income
Net income attributable to the parent company -5.63%-11.78M10.80%-10.01M-7.07%-41.44M-7.36%-9.34M-13.53%-9.73M-6.77%-11.15M-2.09%-11.22M-36.81%-38.7M7.89%-8.7M-23.98%-8.57M
Preferred stock dividends 0.00%6K0.00%6K0.00%24K0.00%6K0.00%6K0.00%6K0.00%6K0.00%24K0.00%6K0.00%6K
Other preferred stock dividends
Net income attributable to common stockholders -5.63%-11.78M10.79%-10.02M-7.07%-41.47M-7.35%-9.34M-13.52%-9.74M-6.77%-11.16M-2.09%-11.23M-36.78%-38.73M7.89%-8.7M-23.96%-8.58M
Basic earnings per share -4.00%-0.2612.00%-0.22-4.49%-0.93-5.00%-0.21-10.00%-0.22-4.17%-0.250.00%-0.25-21.92%-0.8913.04%-0.2-17.65%-0.2
Diluted earnings per share -4.00%-0.2612.00%-0.22-4.49%-0.93-5.00%-0.21-10.00%-0.22-4.17%-0.250.00%-0.25-21.92%-0.8913.04%-0.2-17.65%-0.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data